Standard Biotools (LAB) Asset Writedowns and Impairment (2011 - 2026)
Standard Biotools (LAB) posted quarterly Asset Writedowns and Impairment of $696000.0 for Q1 2026, down 14.6% year-over-year from $815000.0 in Q1 2025, and down 53.38% quarter-over-quarter from $1.5 million in Q4 2025.
Standard Biotools (LAB) Asset Writedowns and Impairment (2011 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Asset Writedowns and Impairment for 9 consecutive years, with $696000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 14.6% year-over-year to $696000.0; the TTM figure through Mar 2026 stood at $3.3 million (up 26.47% YoY), while the FY2025 annual figure was $3.5 million, up 37.4% from the prior year.
- Asset Writedowns and Impairment fell to $696000.0 in Q1 2026 per LAB's latest filing, from $1.5 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $3.5 million in Q2 2022 and bottomed at -$1.1 million in Q3 2022.
- Historically, Asset Writedowns and Impairment has averaged $711125.0 across 5 years, with a median of $580000.0 in 2025.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment tumbled 94.29% — and 2025, when it soared 515.0%.
- Standard Biotools' Asset Writedowns and Impairment stood at -$1.1 million in 2022, then jumped by 146.31% to $496000.0 in 2023, then advanced by 7.46% to $533000.0 in 2024, then jumped by 180.11% to $1.5 million in 2025, then plunged by 53.38% to $696000.0 in 2026.
- Business Quant data shows LAB's Asset Writedowns and Impairment at $696000.0 in Q1 2026, $1.5 million in Q4 2025, and $615000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 696,000.00 |
| Mar 31, 2026 | 696,000.00 |
| Dec 31, 2025 | 1.49 Mn |
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 615,000.00 |
| Sep 30, 2025 | 615,000.00 |
| Jun 30, 2025 | 545,000.00 |
| Jun 30, 2025 | 545,000.00 |
| Mar 31, 2025 | 815,000.00 |
| Mar 31, 2025 | 815,000.00 |
| Dec 31, 2024 | 533,000.00 |
| Dec 31, 2024 | 533,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 655,000.00 |
| Mar 31, 2024 | 655,000.00 |